Press release
Global Systemic Lupus Erythematosus (SLE) Drugs Market Overview by Recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2028
The global systemic lupus erythematosus (SLE) drugs market is anticipated to grow at a considerable CAGR of 7.1% during the forecast period (2022-2028). The continuous involvement of pharmaceutical and biotechnology companies in drugs development is acting as one of the prime factors impacting the growth of the market. Additionally, the high unmet need for current treatment and developments in healthcare technology will also increase the growth rate of the market. Furthermore, the rise in the research and development activities, launch of effective therapies, and emerging new markets will provide beneficial opportunities for the SLE drugs market. For instance, in February 2022, AstraZeneca's Saphnelo (anifrolumab) had received approval from the European Union for the purpose of providing treatment to adult patients with moderate to severe active autoantibody-positive systemic lupus erythematosus (SLE), in spite of obtaining standard therapy.To Request a Sample of our Report on Global Systemic Lupus Erythematosus (SLE) Drugs Market: https://www.omrglobal.com/request-sample/systemic-lupus-erythematosus-sle-drugs-market
However, the lack of infrastructure in low-income countries and the high cost associated with the treatment will impede the growth rate of the market. Additionally, less awareness and complications involved with the disease will further challenge the growth of the SLE drugs market in the forecast period.
Market Coverage
· The market number available for - 2021-2028
· Base year- 2021
· Forecast period- 2022-2028
Segment Covered-
· By Treatment Types
· By Mode of Delivery
Regions Covered-
· North America
· Europe
· Asia-Pacific
Rest of the World
Competitive Landscape- including Astra Zeneca PLC, GlaxoSmithkline plc, ImmuPharma PLC, Johnson and Johnson Pvt. Ltd., Pfizer Inc., and others
(Get 15% Discount on Buying this Report)
A full Report of Global Systemic Lupus Erythematosus (SLE) Drugs Market is Available @ https://www.omrglobal.com/industry-reports/systemic-lupus-erythematosus-sle-drugs-market
Global Systemic Lupus Erythematosus (SLE) Drugs Market Report Segment
By Treatment Types
· Antimalarial Drugs
· Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
· Cytotoxic and Immunosuppressive Drugs
· Biologics
· Others (B-cell Modulators, Immunosuppressive and cytotoxic drugs, T-Cell modulators, Pro-inflammatory and Cytokine inhibitors)
By Mode of Delivery
· Intravenous
· Sub-cutaneous
· Oral
· Topical
Global Systemic Lupus Erythematosus (SLE) Drugs Market Report Segment by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
· Latin America
· Middle East & Africa
Company Profiles
· Amgen, Inc.
· Aurinia Pharmaceuticals Inc.
· Bayer AG
· Bristol-Myers Squibb Co.
· F. Hoffmann-La Roche Ltd.
· Merck Group
· Novartis AG
· Sanofi
· Teva Pharmaceutical Industries Ltd.
· UCB S.A.
Reasons to buy from us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Systemic Lupus Erythematosus (SLE) Drugs Market Overview by Recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2028 here
News-ID: 2601784 • Views: …
More Releases from Orion Market Research

Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033.
Infrastructure as Code (IaC) Service Market Overview
The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market…

Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033.
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview
The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,…

Property Management Service Market Rising Demand and Growth Forecast Through 203 …
Property Management Service Market was valued at approximately USD 17.3 billion. It is anticipated to reach around USD 32.0 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2033.
Property Management Service Market Overview
The Property Management Service Market is witnessing steady growth due to increasing urbanization, rising investments in real estate, and a growing demand for outsourced property management solutions. Property owners are increasingly…

5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033.
5G Chipset Market Overview
The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT…
More Releases for SLE
Systemic Lupus Erythematosus (SLE) Market Detailed Industry Report Analysis 2025 …
Introduction
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease where the immune system attacks multiple organ systems, including skin, joints, kidneys, and blood vessels. It is often unpredictable, with flare-ups and remissions that complicate management. Symptoms range from fatigue and skin rashes to life-threatening organ damage.
While conventional treatments such as corticosteroids, antimalarials, and immunosuppressants remain central, recent years have seen significant advances with biologics, targeted therapies, and precision medicine approaches.…
Systemic Lupus Erythematous SLE Drugs Market Professional Survey Report 2015-202 …
Systemic Lupus Erythematous (SLE) is a chronic autoimmune disease which causes the immune system to mistakenly attack health body tissue. In SLE, body immune system can affect any part of the body, such as joints, organs, eyes, skin, etc. Often SLE can result in symptoms such as malar rash, discoid lesions, sub-acute cutaneous lesions, photosensitivity, oral ulcers, arthritis, serositis, nephropathy, neurologic involvement, thrombocytopenia, haemolytic anemia, fever, Raynaud’s phenomenon, livedo reticularis,…
Systemic lupus erythematosus (SLE) Market: Analysis and Segment Forecasts To 20 …
Systemic lupus erythematosus (lupus) is an autoimmune disease which is characterized by inflammation of tissue in the body. Immune response is directed toward the body’s own cells, resulting in acute or chronic inflammation. Symptoms of lupus are general and hence often mistaken with symptoms of other diseases. This results in unnoticed progression of disease in the body. The disease is more common in women and usually affects individuals in the…
Systemic lupus erythematosus (SLE) Market Research Report : Forecast 2025
In terms of geography, North America accounts for the dominant share in terms of revenue owing to advancements in the treatment of systemic lupus erythematosus and rising awareness among people about the disease. Europe accounts for the second largest market in terms of revenue due to high incidence rate of SLE and increase in research activities in the field of systemic lupus erythematosus. The Asia Pacific market is also witnessing…
Systemic lupus erythematosus (SLE) Market Report by Regional Analysis : forecast …
Systemic lupus erythematosus (lupus) is an autoimmune disease which is characterized by inflammation of tissue in the body. Immune response is directed toward the body’s own cells, resulting in acute or chronic inflammation. Symptoms of lupus are general and hence often mistaken with symptoms of other diseases. This results in unnoticed progression of disease in the body. The disease is more common in women and usually affects individuals in the…
Global Resuscitation Ventilators Market 2017 : Eternity, SIRIUSMED, Siare & SLE
The survey report by Market Research Store is an overview of the global Resuscitation Ventilators market. It covers all the recent trends including key developments in the global market in present and in future. Analyses of the global Resuscitation Ventilators market trends along with the projections of CAGRs (compound annual growth rates) are provided in the research report.
Further, an evaluation of the history of the global market and the basic…